FDA clears Visby Medical’s at-home Covid-19 and Influenza PCR test
July 3, 2026
Visby’s multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
Visby’s multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
In a new study, researchers at the Indian Institute of Science (IISc), in collaboration with clinicians at MS Ramaiah Medical College and Hospitals, explored whether low-frequency ultrasound mechanical stimulation could selectively kill oral cancer cells.
Researchers have finally identified an effective alternative for providing pain relief during the earliest phase of prehospital care, when establishing intravenous access can be difficult. The study is published in The Lancet journal.
A study published in PLOS One by Yao Zhao at Temple University, U.S., and colleagues suggests that wearable devices can provide accurate, longitudinal sleep data to facilitate analyses of changing sleep patterns over time.
SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Powassan virus spreads through infected ticks, raising concern in Maine and Rhode Island, and symptoms can make the infection dangerous.
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing